77 results on '"Sato, Douglas Kazutoshi"'
Search Results
2. ESCLEROSE MÚLTIPLA
3. Neurological syndromes and potential triggers associated with antibodies to neuronal surface antigens
4. AQP4-IgG NMOSD, MOGAD, and double-seronegative NMOSD: is it possible to depict the antibody subtype using magnetic resonance imaging?
5. International Delphi Consensus on the Management of AQP4-IgG+ NMOSD
6. A coffee enriched with guarana, selenium, and l-carnitine (GSC) has nutrigenomic effects on oxi-inflammatory markers of relapsing-remitting multiple sclerosis patients: A pilot study
7. Neuromyelitis optica spectrum disorders: a review with a focus on children and adolescents
8. Neurological sequelae after encephalitis associated with herpes simplex virus in children: systematic review and meta-analysis
9. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria
10. BEYOND THE CRITERIA: A CASE REPORT OF ATYPICAL MANIFESTATIONS IN ANTIPHOSPHOLIPID SYNDROME
11. Asymptomatic MRI lesions in pediatric-onset AQP4-IgG positive NMOSD
12. Neurological sequelae after encephalitis associated with herpes simplex virus in children: systematic review and meta-analysis
13. Immunobiology of neuromyelitis optica spectrum disorders
14. Mechanisms of myelin repair, MRI techniques and therapeutic opportunities in multiple sclerosis
15. Simultaneous bilateral optic neuritis and longitudinally extensive transverse myelitis following vaccination against COVID-19: A case report
16. Treatment of MOG-IgG associated disease in paediatric patients: A systematic review
17. Reduced quality of life in a pediatric-onset Neuromyelitis optica spectrum disorders cohort
18. Myelin-oligodendrocyte glycoprotein antibody-associated disease
19. Healthy aging during the COVID-19 pandemic
20. Detection of MOG-IgG in Clinical Samples by Live Cell-Based Assays: Performance of Immunofluorescence Microscopy and Flow Cytometry
21. Long-term safety of azathioprine for treatment of neuromyelitis optica spectrum disorders
22. Detection of MOG-IgG by cell-based assay: moving from discovery to clinical practice
23. Unraveling B lymphocytes in CNS inflammatory diseases
24. Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients
25. Treatment and outcome of aquaporin-4 antibody–positive NMOSD
26. Characterization of pain syndromes in patients with neuromyelitis optica
27. Experimental Models of Neuroimmunological Disorders: A Review
28. CSF levels of glutamine synthetase and GFAP to explore astrocytic damage in seronegative NMOSD
29. Viral encephalitis: a practical review on diagnostic approach and treatment
30. Viral encephalitis: a practical review on diagnostic approach and treatment
31. Detection of autoantibodies in central nervous system inflammatory disorders: Clinical application of cell-based assays
32. MOG-antibody-associated disease is different from MS and NMOSD and should be considered as a distinct disease entity – Yes
33. Clinical spectrum of inflammatory central nervous system demyelinating disorders associated with antibodies against myelin oligodendrocyte glycoprotein
34. ANTI-PCNA ANTIBODY AND FACIAL NERVE PALSY
35. Role of Glutamatergic Excitotoxicity in Neuromyelitis Optica Spectrum Disorders
36. Persistent MOG-IgG positivity is a predictor of recurrence in MOG-IgG-associated optic neuritis, encephalitis and myelitis
37. Brazilian Consensus for the Treatment of Multiple Sclerosis: Brazilian Academy of Neurology and Brazilian Committee on Treatment and Research in Multiple Sclerosis
38. CSF cytokine profile in MOG-IgG+ neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implications
39. Treatment of MOG-IgG-associated demyelination with Rituximab: a multinational study of 98 patients (S13.003)
40. MOG-IgG-Associated Optic Neuritis, Encephalitis, and Myelitis: Lessons Learned From Neuromyelitis Optica Spectrum Disorder
41. Correlation between the corpus callosum index and brain atrophy, lesion load, and cognitive dysfunction in multiple sclerosis
42. Isolated rhombencephalitis with good clinical recovery
43. MOG-IgG associated optic neuritis is not multiple sclerosis
44. Neuromyelitis Optica Spectrum Disorders
45. Quality of life goes beyond the medical priorities in multiple sclerosis: assessing the impact of social support network
46. Bilateral frontal cortex encephalitis and paraparesis in a patient with anti-MOG antibodies
47. MOG antibody–positive, benign, unilateral, cerebral cortical encephalitis with epilepsy
48. Different etiologies and prognoses of optic neuritis in demyelinating diseases
49. Post-vaccination MDEM associated with MOG antibody in a subclinical Chlamydia infected boy
50. Sometimes less is more in multiple sclerosis drug switching
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.